-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FeUdPnik41DGzap15f42kshY95zuulkW3TiUBtdGvkNEyrCN2i5jbY0l7qXe0pia x5J2v3G1i/px/SVuAAsxHA== 0000849043-05-000002.txt : 20050113 0000849043-05-000002.hdr.sgml : 20050113 20050113155001 ACCESSION NUMBER: 0000849043-05-000002 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050103 FILED AS OF DATE: 20050113 DATE AS OF CHANGE: 20050113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chenard Bertrand L CENTRAL INDEX KEY: 0001314394 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 05528204 BUSINESS ADDRESS: BUSINESS PHONE: 203-315-3025 MAIL ADDRESS: STREET 1: 35 NE INDUSTRIAL ROAD CITY: BRANFORD STATE: CT ZIP: 06405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROGEN CORP CENTRAL INDEX KEY: 0000849043 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222845714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034888201 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 3 1 edgar.xml PRIMARY DOCUMENT X0202 3 2005-01-03 0 0000849043 NEUROGEN CORP NRGN 0001314394 Chenard Bertrand L 35 NE INDUSTRIAL RD BRANFORD CT 06405 0 1 0 0 VP Chemistry Common Stock 4859 I By 401K Plan Stock Options (Right to Buy) 15.25 2002-09-24 2011-09-24 Common Stock 40000 D Stock Options (Right to Buy) 17.48 2002-12-31 Common Stock 5000 D Stock Options (Right to Buy) 3.87 2003-12-19 Common Stock 25000 D Stock Options (Right to Buy) 8.79 2004-12-15 Common Stock 22500 D Stock Options (Right to Buy) 9.50 2005-05-21 Common Stock 40000 D Stock Options (Right to Buy) 9.05 2005-12-21 Common Stock 24000 D On 9/24/2001 the reporting person was granted an option to purchase 40,000 shares pursuant to the Issuer's Amended and Restated 1993 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 10 years from grant date. On 12/31/2001 the reporting person was granted an option to purchase 5,000 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 5 years from each vesting date. On 12/19/2002 the reporting person was granted an option to purchase 17,500 shares pursuant to the Issuer's Amended and Restated 1993 Neurogen Corporation Stock Option Plan, and granted an option to purchase 7,500 shares pursuant to the issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 5 years from each vesting date. On 12/15/2003 the reporting person was granted an option to purchase 22,500 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 5 years from each vesting date. On 5/21/2004 the reporting person was granted an option to purchase 40,000 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 5 years from each vesting date. On 12/21/2004 the reporting person was granted an option to purchase 24,000 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 5 equal annual installments and expire 5 years from each vesting date. by Stephen Davis 2005-01-13 EX-24 2 chenard.htm 
                  POWER OF ATTORNEY









 The undersigned hereby appoints Stephen R. Davis, EVP

and Chief Business Officer of Neurogen Corporation, his

attorney-in-fact and agent in any and all capacities to execute

for and on his behalf filings with the Securities and

Exchange Commission on Forms 3, 4 or 5 pursuant to Section 16

of the Securities and Exchange Act of 1934, as amended, to the

extent that such filings relate to the undersigned's status as

a director or officer of Neurogen Corporation.  The undersigned

further appoints Stephen R. Davis his attorney in fact and agent

to execute any and all amendments to such filings as such

attorney-in-fact and agent deems appropriate.  The undersigned

hereby grants to such attorney-in-fact and agent full power and

authority to do and perform each and every act necessary or

desirable as the undersigned could do in person,hereby ratifying

and confirming all that such attorney in fact and agent may

lawfully do or has done by virtue hereof.



This Power of Attorney shall become effective as of January 11, 2005.







/s/ Bertrand L. Chenard

___________________________

Bertrand L. Chenard
-----END PRIVACY-ENHANCED MESSAGE-----